Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1353859-00-3
|
| gptkbp:developedBy |
gptkb:Achillion_Pharmaceuticals
|
| gptkbp:drugClass |
NS5A inhibitor
|
| gptkbp:hasMolecularFormula |
C24H22Cl2N4O2
|
| gptkbp:hasTherapeuticUse |
treatment of hepatitis C
|
| https://www.w3.org/2000/01/rdf-schema#label |
ACH-3102 hydrochloride
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:synonym |
ACH-3102 HCl
ACH-3102 hydrochloride salt |
| gptkbp:bfsParent |
gptkb:ACH-3102
|
| gptkbp:bfsLayer |
8
|